Local treatment of 'Oligometastases': Wishful thinking is not supported by available evidence.
暂无分享,去创建一个
[1] D. Palma,et al. The Dandelion Dilemma Revisited for Oligoprogression: Treat the Whole Lawn or Weed Selectively? , 2019, Clinical oncology (Royal College of Radiologists (Great Britain)).
[2] J. Dunning,et al. Pulmonary Metastasectomy versus Continued Active Monitoring in Colorectal Cancer (PulMiCC): a multicentre randomised clinical trial , 2019, Trials.
[3] D. Gomez,et al. When Should we Irradiate the Primary in Metastatic Lung Cancer? , 2019, Clinical oncology (Royal College of Radiologists (Great Britain)).
[4] A. Tree. Stereotactic Body Radiotherapy in Metastatic Disease: The Known Unknowns and the Unknown Unknowns. , 2019, Clinical oncology (Royal College of Radiologists (Great Britain)).
[5] Michael Lock,et al. Stereotactic ablative radiotherapy versus standard of care palliative treatment in patients with oligometastatic cancers (SABR-COMET): a randomised, phase 2, open-label trial , 2019, The Lancet.
[6] T. Treasure,et al. Local Treatment of Unresectable Colorectal Liver Metastases: Results of a Randomized Phase II Trial , 2017 .
[7] J. Ledermann,et al. Local Treatment of Unresectable Colorectal Liver Metastases: Results of a Randomized Phase II Trial , 2017, Journal of the National Cancer Institute.
[8] T. Treasure. Oligometastatic cancer: an entity, a useful concept, or a therapeutic opportunity? , 2012, Journal of the Royal Society of Medicine.